Gurkirpal Singh

Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality and economics of rheumatoid arthritis. Arthritis Rheum 2001;44(12):2746-9.
Singh G. Arthritis, Rheumatism, and Aging Medical Information System Post-Marketing Surveillance Program. J Rheumatol 2001;28(5):1174-1179.
Garcia-Garcia J, Gonzalez-Pascual E, Pou-Fernandez J, Singh G, Jimenez R. Development of a Spanish (Castillian) version of the Childhood Health Assessment Questionnaire. Measurement of health status in children with juvenile chronic arthritis. Clin Exp Rheumatol. 2000;18(1):95-102.
Lipani J, Strand V, Woodworth T, et al. A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis. J Rheumatol. 2000;27(4):827-30.
Singh G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs - a view from the ARAMIS database. Am J Therapeutics. 2000;7(2):115-122.
Wong J, Ramey D, Singh G. The morbidity, mortality and economics of rheumatoid arthritis. Selected for presentation at the Economics Mini-symposium of the 64th Annual Scientific Meeting of the American College of Rheumatology. Arthritis Rheum. 2000;43((Suppl)):S389.
Ramey D, Rausch P, Schettler J, Singh G. Serious infections in rheumatoid arthritis : What is the scope of the problem? Arthritis Rheum. 1999;42:S279.
Schettler J, Wong J, Ramey D, Singh G. Prednisone use significantly increases the risk of hip fractures in rheumatoid arthritis. Arthritis Rhem. 1999;42:S136.
Singh G, Ramey D, Rausch P, Schettler J. Serious infections in rheumatoid arthritis: Relationship to immunosuppressive use. Arthritis Rheum. 1999;42:S42.
Singh G, Ramey D, Triadafilopoulos G. Early Experience with selective COX-2 inhibitors: Safely profile in over 340,000 patinet years of use. Arthritis Rheum. 1999;42:S296.
Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol. 1999;26 Suppl 56:18-24.
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888-99.
Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B):31S-38S.
Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective-- 1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl. 1998;51:8-16.
Singh G, Triadafilopoulos G, Brown B, Balise R. GI score: A simple self-assessment instrument to quantify the risk of serious NSAID-related GI cinplications in RA and OA. Arthritis Rheum. 1998;41:S59.
Fries J, Williams C, Singh G, Ramey D. Response to therapy in rheumatoid arthritis is influenced by immediately prior therapy. Jnl of Rheumatology. 1997;24:838-44.
Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum. 1996;39(4):616-22.
Khraishi MM, Singh G. The role of anti-malarials in rheumatoid arthritis--the American experience. Lupus. 1996;5 Suppl 1:S41-4.
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med. 1996;156(14):1530-6.
Singh G, Terry R, Ramey D, Wolfe F, Fries J. Long-term medical costs and outcomes are significantly asociated with early changes in disability in rheumatoid arthritis. Arthritis Rheum. 1996;39:S318.
Fries JF, Singh G. Glucocorticoids and joint destruction in rheumatoid arthritis. N Engl J Med. 1995;333(23):1569; discussion 1570.
Fries JF, Singh G, Morfeld D, Hubert HB, Lane NE, Brown BW. Running and the development of disability with age. Ann Intern Med. 1994;121(7):502-9.
Montgomery E, Lieberman A, Singh G, Fries J. Patient education and health promotion can be effective in Parkinson's Disease: A randomized controlled trial. Amer Jnl of Medicine. 1994;97:429-435.
Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37(12):1761-9.
Singh G, Ramey DR, Morfeld D, Fries JF. Comparative toxicity of non-steroidal anti-inflammatory agents. Pharmacol Ther. 1994;62(1-2):175-91.
Fries J, Singh G, Morfeld D, Hubert H, Lane N, Brown B. Running activity and the development of disability with age: 8-year longitudinal study. . 1993.
Fries JF, Ramey DR, Singh G, Morfeld D, Bloch DA, Raynauld JP. A reevaluation of aspirin therapy in rheumatoid arthritis. Arch Intern Med. 1993;153(21):2465-71.
Singh G, Fries JF, Williams CA, Zatarain E, Spitz P, Bloch DA. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. J Rheumatol. 1991;18(2):188-94.
Fries J, Singh G, Lenert L, Furst D. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate. Arthritis Rheum. 1990;33:1611-1619.
Fries J, Spitz P, Williams C, Singh G, Bloch D, Hubert H. A toxicity index for comparison of side effects among different drugs. Arthritis Rheum. 1990;33:121-130.
Fries JF, Singh G, Bloch DA, Calin A. The natural history of ankylosing spondylitis: is the disease really changing? J Rheumatol. 1989;16(7):860-3.
Singh G, Fries JF, Spitz P, Williams CA. Toxic effects of azathioprine in rheumatoid arthritis. A national post- marketing perspective. Arthritis Rheum. 1989;32(7):837-43.
Osial TA, Jr., Whiteside TL, Buckingham RB, et al. Clinical and serologic study of Sjogren's syndrome in patients with progressive systemic sclerosis. Arthritis Rheum. 1983;26(4):500-8.
Lynch CJ, Singh G, Whiteside TL, Rodnan GP, Medsger TA, Jr., Rabin BS. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma). J Clin Immunol. 1982;2(4):314-8.

ARAMIS | Investigators | Research | Publications | HAQ | Pharmaceutical Collaborations